Overall, these data indicate Cnr2 knock-out attenuates the progression of obesity by a mechanism distinct from that elicited by CB1 antagonism, possibly by increasing both lipid oxidation and fecal fat excretion. The gene discussed is CNR2; the disease is obesity due to melanocortin 4 receptor deficiency.